Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Human Mesenchymal Stem Cells Display Reduced Expression of CD105 after Culture in Serum-Free Medium.

Mark P, Kleinsorge M, Gaebel R, Lux CA, Toelk A, Pittermann E, David R, Steinhoff G, Ma N.

Stem Cells Int. 2013;2013:698076. doi: 10.1155/2013/698076. Epub 2013 Sep 30.

2.

Properties and growth of human bone marrow mesenchymal stromal cells cultivated in different media.

Turnovcova K, Ruzickova K, Vanecek V, Sykova E, Jendelova P.

Cytotherapy. 2009;11(7):874-85. doi: 10.3109/14653240903188947.

PMID:
19903100
3.

Influence of culture medium on smooth muscle cell differentiation from human bone marrow-derived mesenchymal stem cells.

Gong Z, Calkins G, Cheng EC, Krause D, Niklason LE.

Tissue Eng Part A. 2009 Feb;15(2):319-30. doi: 10.1089/ten.tea.2008.0161.

4.
5.

Characterization of mesenchymal stem cell subpopulations from human amniotic membrane with dissimilar osteoblastic potential.

Leyva-Leyva M, Barrera L, López-Camarillo C, Arriaga-Pizano L, Orozco-Hoyuela G, Carrillo-Casas EM, Calderón-Pérez J, López-Díaz A, Hernandez-Aguilar F, González-Ramírez R, Kawa S, Chimal-Monroy J, Fuentes-Mera L.

Stem Cells Dev. 2013 Apr 15;22(8):1275-87. doi: 10.1089/scd.2012.0359. Epub 2013 Jan 29.

PMID:
23211052
6.

Culture of human mesenchymal stem cells using a candidate pharmaceutical grade xeno-free cell culture supplement derived from industrial human plasma pools.

Díez JM, Bauman E, Gajardo R, Jorquera JI.

Stem Cell Res Ther. 2015 Mar 13;6:28. doi: 10.1186/s13287-015-0016-2.

7.

[Pooled Umbilical Cord Blood Plasma for Culturing UCMSC and Ex Vivo Expanding Umbilical Cord Blood CD34⁺ Cells].

Wu JY, Lu Y, Chen JS, Wu SQ, Tang XW, Li Y.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Aug;23(4):1112-9. doi: 10.7534/j.issn.1009-2137.2015.04.040. Chinese.

PMID:
26314456
8.

A defined medium and substrate for expansion of human mesenchymal stromal cell progenitors that enriches for osteo- and chondrogenic precursors.

Hudson JE, Mills RJ, Frith JE, Brooke G, Jaramillo-Ferrada P, Wolvetang EJ, Cooper-White JJ.

Stem Cells Dev. 2011 Jan;20(1):77-87. doi: 10.1089/scd.2009.0497. Epub 2010 Nov 9.

PMID:
20446813
9.

Stem cell-derived extracellular matrix enables survival and multilineage differentiation within superporous hydrogels.

Köllmer M, Keskar V, Hauk TG, Collins JM, Russell B, Gemeinhart RA.

Biomacromolecules. 2012 Apr 9;13(4):963-73. doi: 10.1021/bm300332w. Epub 2012 Mar 22.

10.

Growth factor-defined culture medium for human mesenchymal stem cells.

Mimura S, Kimura N, Hirata M, Tateyama D, Hayashida M, Umezawa A, Kohara A, Nikawa H, Okamoto T, Furue MK.

Int J Dev Biol. 2011;55(2):181-7. doi: 10.1387/ijdb.103232sm.

11.

Human mesenchymal stem cells from the umbilical cord matrix: successful isolation and ex vivo expansion using serum-/xeno-free culture media.

Simões IN, Boura JS, dos Santos F, Andrade PZ, Cardoso CM, Gimble JM, da Silva CL, Cabral JM.

Biotechnol J. 2013 Apr;8(4):448-58. doi: 10.1002/biot.201200340. Epub 2013 Mar 7.

PMID:
23420807
12.

Synthetic surface for expansion of human mesenchymal stem cells in xeno-free, chemically defined culture conditions.

Dolley-Sonneville PJ, Romeo LE, Melkoumian ZK.

PLoS One. 2013 Aug 5;8(8):e70263. doi: 10.1371/journal.pone.0070263. Print 2013.

13.

Human mesenchymal stem cells maintain their phenotype, multipotentiality, and genetic stability when cultured using a defined xeno-free human plasma fraction.

Blázquez-Prunera A, Díez JM, Gajardo R, Grancha S.

Stem Cell Res Ther. 2017 Apr 27;8(1):103. doi: 10.1186/s13287-017-0552-z.

14.

Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum-free microcarrier process.

Heathman TR, Glyn VA, Picken A, Rafiq QA, Coopman K, Nienow AW, Kara B, Hewitt CJ.

Biotechnol Bioeng. 2015 Aug;112(8):1696-707. doi: 10.1002/bit.25582. Epub 2015 Apr 20.

15.

[Comparison of the biological characteristics of serum-free and fetal bovine serum-contained medium cultured umbilical cord-derived mesenchymal stem cells].

Yang T, Chen GH, Xue SL, Qiao M, Liu HW, Tian H, Qiao SM, Chen F, Chen ZZ, Sun AN, Wu DP.

Zhonghua Xue Ye Xue Za Zhi. 2012 Sep;33(9):715-9. doi: 10.3760/cma.j.issn.0253-2727.2012.09.006. Chinese.

PMID:
23336223
16.

[Effectivity of the novel serum-free medium STK2 for proliferating human mesenchymal stem cells].

Ishikawa I, Sawada R, Kato Y, Tsuji K, Shao J, Yamada T, Kato R, Tsuchiya T.

Yakugaku Zasshi. 2009 Mar;129(3):381-4. Japanese.

17.

Optimization and scale-up culture of human endometrial multipotent mesenchymal stromal cells: potential for clinical application.

Rajaraman G, White J, Tan KS, Ulrich D, Rosamilia A, Werkmeister J, Gargett CE.

Tissue Eng Part C Methods. 2013 Jan;19(1):80-92. doi: 10.1089/ten.TEC.2011.0718. Epub 2012 Aug 2.

18.

Noninvasive MRI and multilineage differentiation capability of ferritin-transduced human mesenchymal stem cells.

Kim HS, Woo J, Choi Y, Hwang EH, Choi SK, Cho KW, Moon WK.

NMR Biomed. 2015 Feb;28(2):168-79. doi: 10.1002/nbm.3236. Epub 2014 Dec 1.

PMID:
25448225
19.

Evaluation of methods for cultivating limbal mesenchymal stromal cells.

Bray LJ, Heazlewood CF, Atkinson K, Hutmacher DW, Harkin DG.

Cytotherapy. 2012 Sep;14(8):936-47. doi: 10.3109/14653249.2012.684379. Epub 2012 May 15.

PMID:
22587591
20.

Human adipose-derived mesenchymal stem cells in vitro: evaluation of an optimal expansion medium preserving stemness.

Baer PC, Griesche N, Luttmann W, Schubert R, Luttmann A, Geiger H.

Cytotherapy. 2010;12(1):96-106. doi: 10.3109/14653240903377045.

PMID:
19929458

Supplemental Content

Support Center